Literature DB >> 10597222

Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.

G Baldassarre1, M V Barone, B Belletti, C Sandomenico, P Bruni, S Spiezia, A Boccia, M T Vento, A Romano, S Pepe, A Fusco, G Viglietto.   

Abstract

Hexamethylen-bisacetamide (HMBA) represents the prototype of a group of hybrid polar compounds, which induce differentiation in a variety of transformed cells including human embryonal carcinoma cells. Therefore, HMBA has been used in the differentiation therapy of cancer for patients with both hematological and solid malignancies. Upon HMBA treatment, the embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) accumulates in G1 and undergoes terminal differentiation. Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4). When HMBA differentiation was induced in the presence of p27 antisense oligonucleotides, NT2/D1 cells failed to arrest growth properly and, in parallel with the reduction of the anti-apoptotic Bcl-2 gene expression, cells underwent massive programmed cell death. Conversely, constitutive expression of p27 into NT2/D1 cells induced a marked reduction in the growth potential of these cells and partially reproduced HMBA-induced modification of surface antigen expression (down-regulation of SSEA-3 expression and up-regulation of VINIS-53 expression). Expression of p21 induced growth arrest but not differentiation. Likewise, inhibition of CDK2 by transfection of a dominant negative CDK2 in NT2/D1 cells or treatment with the kinase inhibitor olomucine induced growth arrest but not differentiation. Therefore, we propose that p27 represents a crucial molecule in HMBA signaling that cannot be replaced by p21. Furthermore, the results obtained with CDK2 inhibitors demonstrate that the block of CDK2 activity is sufficient for growth arrest but not for cell differentiation and suggest that, at least in these cells, growth arrest and differentiation are regulated by two overlapping but different pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597222     DOI: 10.1038/sj.onc.1203031

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility.

Authors:  Giovanna Maria Pierantoni; Francesco Esposito; Mara Tornincasa; Cinzia Rinaldo; Giuseppe Viglietto; Silvia Soddu; Alfredo Fusco
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

2.  Cloning and characterization of mouse cullin4B/E3 ubiquitin ligase.

Authors:  Rachana Tripathi; K Seetharama Sastry; Satya Keerthi Kota; Usha K Srinivas
Journal:  J Biosci       Date:  2005-06       Impact factor: 1.826

3.  FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.

Authors:  Andrea Vecchione; Hideshi Ishii; Gustavo Baldassarre; Pierfrancesco Bassi; Francesco Trapasso; Hansjuerg Alder; Francesco Pagano; Leonard G Gomella; Carlo M Croce; Raffaele Baffa
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.

Authors:  G Baldassarre; B Belletti; P Bruni; A Boccia; F Trapasso; F Pentimalli; M V Barone; G Chiappetta; M T Vento; S Spiezia; A Fusco; G Viglietto
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.

Authors:  Maria Letizia Motti; Daniela Califano; Giancarlo Troncone; Carmela De Marco; Ilenia Migliaccio; Emiliano Palmieri; Luciano Pezzullo; Lucio Palombini; Alfredo Fusco; Giuseppe Viglietto
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.

Authors:  Gustavo Baldassarre; Sabrina Battista; Barbara Belletti; Sanjay Thakur; Francesca Pentimalli; Francesco Trapasso; Monica Fedele; Giovanna Pierantoni; Carlo M Croce; Alfredo Fusco
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells.

Authors:  Yan-Yi Wang; Xingming Deng; Lijun Xu; Fengqin Gao; Tammy Flagg; W Stratford May
Journal:  Exp Hematol       Date:  2007-11-26       Impact factor: 3.084

8.  E2F1 sumoylation as a protective cellular mechanism in oxidative stress response.

Authors:  Joshua D Graves; Yu-Ju Lee; Kang Liu; Gang Li; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-15       Impact factor: 11.205

9.  P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells.

Authors:  Min Wei; Zhiwei Wang; Hongliang Yao; Zhongyin Yang; Qing Zhang; Bingya Liu; Yingyan Yu; Liping Su; Zhenggang Zhu; Qinlong Gu
Journal:  BMC Cancer       Date:  2011-03-27       Impact factor: 4.430

10.  Immunohistochemical localization of mdm-2, p27Kip1 and bcl-2 in Warthin's tumor of the parotid gland.

Authors:  Ehab S Abd-Elhamid; Marwa M Elshafei
Journal:  Diagn Pathol       Date:  2009-05-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.